Participants in the BANDIT (baricitinib in new onset type 1 diabetes) trial must be aged 10 - 30 years old, and must have been diagnosed with type 1 diabetes within the last 100 days.
Participants will be required to attend at one of three sites in Melbourne: The Royal Melbourne Hospital, The Royal Children’s Hospital or St Vincent’s Hospital Melbourne, or at one site in Adelaide – the Women’s and Children’s Hospital.
For more information, or to see if you are eligible, you can fill out an enquiry form and someone from the trial team will get back to you.
Alternatively, you can contact the BANDIT trial coordinator via email or by telephone on 0450 323 962, or Associate Professor John Wentworth via email or by telephone on (03) 9342 7344.
Before you make any decision about your or your child’s participation in the trial, you will be given more detailed information about the trial medicine, the trial, and any other relevant information by research staff. To proceed, a consent form needs to be signed by the participant or authorised guardian.
Please note that all applications to participate in the BANDIT trial will be assessed, but as we have almost reached our maximum participant capacity, we cannot guarantee your place in the trial. Thank you for your interest and understanding.